The Latest in Thrombosis

Betrixaban receives FDA approval for VTE prophylaxis in adults

June 26, 2017

Fostamatinib under review by FDA for chronic ITP

June 21, 2017

Researchers design new, safer antiplatelet drug based on snake venom

June 10, 2017

Thrombosis

Team finds inappropriate dosing of blood thinners

June 8, 2017

Thrombosis

Recombinant coagulation factor IX approved for hemophilia B

June 7, 2017

Preventing thrombosis without increasing bleeding risk

June 1, 2017

Thrombosis

EMA recommends orphan designation for hemophilia B product

June 1, 2017

AstraZeneca recalls lot of Brilinta in US

May 27, 2017

Finding could lead to ‘Holy Grail’ of antithrombotic therapy

May 26, 2017

Thrombosis

PK-guided prophylaxis reduces dosing, still prevents bleeds

May 24, 2017

Thrombosis

SFDA approves product for hemophilia A

May 21, 2017

Thrombosis

Bivalirudin not superior to heparin in real-world analysis

May 19, 2017

Thrombosis

Gene therapy granted fast track status for hemophilia A

May 17, 2017

Thrombosis

Company stops developing hemophilia therapy

May 12, 2017

Thrombosis

EMA recommends drug receive orphan designation for PNH

May 11, 2017